IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 203 filers reported holding IMPAX LABORATORIES INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,265,000 | -73.3% | 100,000 | -50.0% | 0.63% | -25.9% |
| Q3 2016 | $4,740,000 | +196.1% | 200,000 | +300.0% | 0.84% | +44.0% |
| Q1 2016 | $1,601,000 | -25.1% | 50,000 | 0.0% | 0.59% | -16.5% |
| Q4 2015 | $2,138,000 | -19.0% | 50,000 | -33.3% | 0.70% | -32.3% |
| Q3 2015 | $2,641,000 | -54.0% | 75,000 | -40.0% | 1.04% | -42.6% |
| Q2 2015 | $5,740,000 | +63.3% | 125,000 | +66.7% | 1.81% | +22.4% |
| Q1 2015 | $3,515,000 | -44.5% | 75,000 | -62.5% | 1.48% | -51.7% |
| Q4 2014 | $6,336,000 | +434.2% | 200,000 | +300.0% | 3.06% | +383.0% |
| Q3 2014 | $1,186,000 | -47.3% | 50,000 | -33.3% | 0.63% | -39.6% |
| Q2 2014 | $2,249,000 | -41.3% | 75,000 | -48.3% | 1.05% | -40.8% |
| Q1 2014 | $3,831,000 | +204.8% | 145,000 | +190.0% | 1.77% | +147.3% |
| Q4 2013 | $1,257,000 | – | 50,000 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |